Key Capital Management
BMY icon

Key Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Key Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.8K Buy
141
+10
+8% +$632 ﹤0.01% 395
2026
Q2 		$7.55K Buy
131
+121
+1,210% +$6.95K ﹤0.01% 370
2026
Q1 		$607 Buy
10
+2
+25% +$117 ﹤0.01% 640
2025
Q4 		$432 Buy
+8
New +$385 ﹤0.01% 487

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Key Capital Management's BMY Position: Q3 2026 in Review

Key Capital Management increased its Bristol-Myers Squibb (BMY) stake by 7.6% in Q3 2026, buying an estimated $632 and bringing the position to 141 shares worth $8.8K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

Key Capital Management first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Key Capital Management held 141 shares of Bristol-Myers Squibb worth $8.8K as of Q3 2026.
  • Key Capital Management bought 10 Bristol-Myers Squibb shares in Q3 2026, an estimated $632.
  • Bristol-Myers Squibb made up ﹤0.01% of Key Capital Management's portfolio in Q3 2026, its #395 holding.
  • Key Capital Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.